Crotti, L;
Spazzolini, C;
Tester, DJ;
Ghidoni, A;
Baruteau, A-E;
Beckmann, B-M;
Behr, ER;
Bennett, JS;
Bezzina, CR;
Bhuiyan, ZA;
et al.
Crotti, L; Spazzolini, C; Tester, DJ; Ghidoni, A; Baruteau, A-E; Beckmann, B-M; Behr, ER; Bennett, JS; Bezzina, CR; Bhuiyan, ZA; Celiker, A; Cerrone, M; Dagradi, F; De Ferrari, GM; Etheridge, SP; Fatah, M; Garcia-Pavia, P; Al-Ghamdi, S; Hamilton, RM; Al-Hassnan, ZN; Horie, M; Jimenez-Jaimez, J; Kanter, RJ; Kaski, JP; Kotta, M-C; Lahrouchi, N; Makita, N; Norrish, G; Odland, HH; Ohno, S; Papagiannis, J; Parati, G; Sekarski, N; Tveten, K; Vatta, M; Webster, G; Wilde, AAM; Wojciak, J; George, AL; Ackerman, MJ; Schwartz, PJ
(2019)
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.
Eur Heart J, 40 (35).
pp. 2964-2975.
ISSN 1522-9645
https://doi.org/10.1093/eurheartj/ehz311
SGUL Authors: Behr, Elijah Raphael
![[img]](https://openaccess.sgul.ac.uk/style/images/fileicons/application_vnd.openxmlformats-officedocument.wordprocessingml.document.png) |
Microsoft Word (.docx)
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (214kB)
|
Abstract
AIMS: Calmodulinopathies are rare life-threatening arrhythmia syndromes which affect mostly young individuals and are, caused by mutations in any of the three genes (CALM 1-3) that encode identical calmodulin proteins. We established the International Calmodulinopathy Registry (ICalmR) to understand the natural history, clinical features, and response to therapy of patients with a CALM-mediated arrhythmia syndrome. METHODS AND RESULTS: A dedicated Case Report File was created to collect demographic, clinical, and genetic information. ICalmR has enrolled 74 subjects, with a variant in the CALM1 (n = 36), CALM2 (n = 23), or CALM3 (n = 15) genes. Sixty-four (86.5%) were symptomatic and the 10-year cumulative mortality was 27%. The two prevalent phenotypes are long QT syndrome (LQTS; CALM-LQTS, n = 36, 49%) and catecholaminergic polymorphic ventricular tachycardia (CPVT; CALM-CPVT, n = 21, 28%). CALM-LQTS patients have extremely prolonged QTc intervals (594 ± 73 ms), high prevalence (78%) of life-threatening arrhythmias with median age at onset of 1.5 years [interquartile range (IQR) 0.1-5.5 years] and poor response to therapies. Most electrocardiograms (ECGs) show late onset peaked T waves. All CALM-CPVT patients were symptomatic with median age of onset of 6.0 years (IQR 3.0-8.5 years). Basal ECG frequently shows prominent U waves. Other CALM-related phenotypes are idiopathic ventricular fibrillation (IVF, n = 7), sudden unexplained death (SUD, n = 4), overlapping features of CPVT/LQTS (n = 3), and predominant neurological phenotype (n = 1). Cardiac structural abnormalities and neurological features were present in 18 and 13 patients, respectively. CONCLUSION: Calmodulinopathies are largely characterized by adrenergically-induced life-threatening arrhythmias. Available therapies are disquietingly insufficient, especially in CALM-LQTS. Combination therapy with drugs, sympathectomy, and devices should be considered.
Item Type: |
Article
|
Additional Information: |
This is a pre-copyedited, author-produced version of an article accepted for publication in European Heart Journal following peer review. The version of record Lia Crotti, Carla Spazzolini, David J Tester, Alice Ghidoni, Alban-Elouen Baruteau, Britt-Maria Beckmann, Elijah R Behr, Jeffrey S Bennett, Connie R Bezzina, Zahurul A Bhuiyan, Alpay Celiker, Marina Cerrone, Federica Dagradi, Gaetano M De Ferrari, Susan P Etheridge, Meena Fatah, Pablo Garcia-Pavia, Saleh Al-Ghamdi, Robert M Hamilton, Zuhair N Al-Hassnan, Minoru Horie, Juan Jimenez-Jaimez, Ronald J Kanter, Juan P Kaski, Maria-Christina Kotta, Najim Lahrouchi, Naomasa Makita, Gabrielle Norrish, Hans H Odland, Seiko Ohno, John Papagiannis, Gianfranco Parati, Nicole Sekarski, Kristian Tveten, Matteo Vatta, Gregory Webster, Arthur A M Wilde, Julianne Wojciak, Alfred L George, Michael J Ackerman, Peter J Schwartz, Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry, European Heart Journal, Volume 40, Issue 35, 14 September 2019, Pages 2964–2975 is available online at: https://doi.org/10.1093/eurheartj/ehz311 |
Keywords: |
Calmodulin, Cathecolaminergic polymorphic ventricular tachycardia, Idiopathic ventricular fibrillation, Long QT syndrome, Sudden death, Calmodulin, Cathecolaminergic polymorphic ventricular tachycardia, Idiopathic ventricular fibrillation, Long QT syndrome, Sudden death, 1102 Cardiovascular Medicine And Haematology, Cardiovascular System & Hematology |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
Eur Heart J |
ISSN: |
1522-9645 |
Language: |
eng |
Dates: |
Date | Event |
---|
14 September 2019 | Published | 6 June 2019 | Published Online | 29 April 2019 | Accepted |
|
Publisher License: |
Publisher's own licence |
Projects: |
|
PubMed ID: |
31170290 |
![](http://static.pubmed.gov/portal/portal3rc.fcgi/2745237/img/27842) |
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/110942 |
Publisher's version: |
https://doi.org/10.1093/eurheartj/ehz311 |
Statistics
Item downloaded times since 21 Jun 2019.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |